Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downregulated LINC02381 Predicts Tumor Progression and Correlates with Poor Survival in Gastric Cancer.

International journal of general medicine·2026
Same author

Multi-Field Coupled Cyclic Degradation Mechanisms of Alumina Ceramic Fiber Ropes.

Nanomaterials (Basel, Switzerland)·2026
Same author

Internalized Components of Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties.

bioRxiv : the preprint server for biology·2026
Same author

Biochar and milk vetch synergistically enhance rice yield and soil fertility via regulating N-cycling in reddish paddy fields.

Frontiers in plant science·2026
Same author

Population pharmacokinetic-pharmacodynamic analysis and dose optimisation of ciprofol in paediatric anaesthesia.

British journal of anaesthesia·2026
Same author

TMEM216 inhibits breast cancer lung metastasis by modulating IGF1R-IRS4 signaling pathway.

Nature communications·2026

Related Experiment Video

Updated: Jul 14, 2026

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.7K

Fully biologic endothelialized-tissue-engineered vascular conduits provide antithrombotic function and graft patency.

Jinkyu Park1, Muhammad Riaz2, Lingfeng Qin3

  • 1Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine Yale School of Medicine, New Haven, CT 06511, USA; Yale Stem Cell Center, New Haven, CT 06520, USA; Department of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon-si 24252, Gangwon-Do, South Korea.

Cell Stem Cell
|December 7, 2024
PubMed
Summary

Engineered vascular grafts using stem cells show promise for congenital heart defects. These new grafts prevent clotting and integrate well, offering a potential new therapy for patients.

Keywords:
endothelial cellflow bioreactorhuman induced pluripotent stem cellshear stress trainingsingle ventricle congenital heart defecttissue-engineered vascular conduit

More Related Videos

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.0K
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.4K

Related Experiment Videos

Last Updated: Jul 14, 2026

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
11:17

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring

Published on: April 3, 2015

11.7K
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.0K
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
09:38

Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method

Published on: March 27, 2017

8.4K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Tissue-engineered vascular conduits (TEVCs) show potential for treating single-ventricle congenital heart defects (SVCHDs).
  • Clinical use of TEVCs is limited by graft stenosis observed in previous trials.

Purpose of the Study:

  • To develop endothelialized TEVCs using human induced pluripotent stem cell (hiPSC)-derived endothelial cells (ECs) to improve graft function and reduce stenosis.
  • To evaluate the antithrombotic properties and host integration of these novel TEVCs in vivo.

Main Methods:

  • Decellularized human umbilical arteries were coated with hiPSC-derived ECs.
  • Grafts underwent shear stress training in flow bioreactors.
  • Implantation as interposition inferior vena cava grafts in nude rats was performed.

Main Results:

  • Endothelialized TEVCs demonstrated immediate antithrombotic function.
  • Accelerated host EC recruitment and graft patency were observed post-implantation.
  • No thrombus formation occurred, and complete host EC replacement was achieved.

Conclusions:

  • Developed endothelialized TEVCs offer immediate antithrombotic benefits and promote host integration.
  • These fully biologic TEVCs represent a promising innovative therapy for SVCHDs.
  • The findings lay the groundwork for future clinical applications of hiPSC-derived EC-based vascular grafts.